Outcomes by Clinical and Molecular Features in Children With Medulloblastoma Treated With Risk – Adapted Therapy: Results of an International Phase III Trial (SJMB03)
Authors:Kyle SmithGeoffrey McCowagePaulNorthcottTong LinRichard Cohn
+ 33 more
Murali Chintagumpala (United States, Americas)Michael FisherAnita MahajanMatthew KrasinJack SuClinton StewartUte Bartels (United States, Americas)Alberto BroniscerTal SchechterIvo BuchhalterTim HassallRuth TatevossianThomas RobertsonBrent OrrWayne NichollsGeoff NealeSridharan GururanganPaul Klimo (United States, Americas)Frederick Boop (United States, Americas)Kristin SchroederAshok SrinivasanEric Bouffet (Canada, Americas)Michael Sullivan (United States, Americas)Stefan PfisterThomas Merchant (United States, Americas)Greg WheelerRichard GilbertsonAmar Gajjar (United States, Americas)Jordan Hansford (United States, Americas)Arzu Onar ThomasGiles Robinson (United States, Americas)Stewart KellieDavid Ellison
Date: January 1, 2021Please create a free account or log in to view this item
Registration is free, quick and easy. Simply register and complete your profile to get access. If you already have an account with the ISPN Library or ISPN Guide, login below.
Create an account
Login
Register
Log in using your ISPN Guide or ISPN Library credentials
Not yet registered? Join now









